1404P Update results of paclitaxel and cisplatin in combination with anlotinib as first-line treatment for patients with advanced ESCC: A multicenter, single-arm, open-label phase II clinical trial

Annals of Oncology ◽

10.1016/j.annonc.2021.08.1513 ◽

2021 ◽

Vol 32 ◽

pp. S1058

Author(s):

J. Wang ◽

T. Wu ◽

Y-G. Hong ◽

S-X. Luo ◽

N. Li ◽

...

Keyword(s):

Clinical Trial ◽

Phase Ii ◽

Phase Ii Clinical Trial ◽

Line Treatment ◽

First Line ◽

Open Label ◽

Open Label Phase ◽

First Line Treatment

Download Full-text

Randomized, Open, Prospective, Phase II Clinical Trial of Doxorubicin (DOXO) vs. Trabectedin Plus Doxo in the First-Line Treatment of Patients (PTS) with Advanced Non-Operable and/or Metastatic Soft Tissue Sarcomas (STS): Geis-20 Study

Annals of Oncology ◽

10.1016/s0923-7534(20)34065-5 ◽

2012 ◽

Vol 23 ◽

pp. ix490 ◽

Cited By ~ 1

Author(s):

J. Martin Broto ◽

X. Garcia Del Muro ◽

A. Lopez-Pousa ◽

R. Las De Penas ◽

J. Maurel ◽

...

Keyword(s):

Clinical Trial ◽

Soft Tissue ◽

Phase Ii ◽

Soft Tissue Sarcomas ◽

Phase Ii Clinical Trial ◽

Line Treatment ◽

First Line ◽

Prospective Phase ◽

First Line Treatment

Download Full-text

A multicentre, open-label phase II study of Irinotecan, capecitabine (Xeloda®), and Oxaliplatin (IXO) as first-line treatment in patients with metastatic gastric or gastroesophageal junction (GEJ) adenocarcinoma

Investigational New Drugs ◽

10.1007/s10637-018-0599-4 ◽

2018 ◽

Vol 36 (4) ◽

pp. 674-682 ◽

Cited By ~ 1

Author(s):

Arthur Lui ◽

Karen Mulder ◽

Christine Brezden-Masley ◽

Michael Vickers ◽

Jose Monzon ◽

...

Keyword(s):

Phase Ii ◽

Phase Ii Study ◽

Gastroesophageal Junction ◽

Line Treatment ◽

First Line ◽

Open Label ◽

Open Label Phase ◽

First Line Treatment

Download Full-text

Chemotherapy with or without autologous cytokine-induced killer cell transfusion as the first-line treatment for stage IV gastrointestinal cancer: a phase II clinical trial

Journal of Cancer Research and Clinical Oncology ◽

10.1007/s00432-016-2127-2 ◽

2016 ◽

Vol 142 (6) ◽

pp. 1315-1323 ◽

Cited By ~ 2

Author(s):

Ying-Chun Xu ◽

Qi Xu ◽

Jun-Jian Li ◽

Xiao-Feng Gu ◽

Xiao-Lin Lin ◽

...

Keyword(s):

Clinical Trial ◽

Phase Ii ◽

Gastrointestinal Cancer ◽

Killer Cell ◽

Stage Iv ◽

Phase Ii Clinical Trial ◽

Line Treatment ◽

First Line ◽

First Line Treatment

Download Full-text

Dose-adjusted EPOCH regimen as first-line treatment for non-Hodgkin lymphoma-associated hemophagocytic lymphohistiocytosis: a single-arm, open-label, phase II trial

Haematologica ◽

10.3324/haematol.2019.220301 ◽

2019 ◽

Vol 105 (1) ◽

pp. e29-e32 ◽

Cited By ~ 2

Author(s):

Jin-Hua Liang ◽

Li Wang ◽

Hua-Yuan Zhu ◽

Jun Qian ◽

Hui Liao ◽

...

Keyword(s):

Hodgkin Lymphoma ◽

Phase Ii ◽

Hemophagocytic Lymphohistiocytosis ◽

Phase Ii Trial ◽

Line Treatment ◽

First Line ◽

Open Label ◽

Non Hodgkin Lymphoma ◽

Open Label Phase ◽

First Line Treatment

Download Full-text

A multicentre, open-label phase II study of irinotecan, capecitabine, and oxaliplatin (IXO) as first-line treatment in patients with metastatic gastric or gastroesophageal junction (GEJ) adenocarcinoma.

Journal of Clinical Oncology ◽

10.1200/jco.2016.34.15_suppl.4032 ◽

2016 ◽

Vol 34 (15_suppl) ◽

pp. 4032-4032

Author(s):

Arthur Gregory Ang Lui ◽

Karen E. Mulder ◽

Christine Brezden-Masley ◽

Michael M. Vickers ◽

Jose Gerard Monzon ◽

...

Keyword(s):

Phase Ii ◽

Phase Ii Study ◽

Gastroesophageal Junction ◽

Line Treatment ◽

First Line ◽

Open Label ◽

Open Label Phase ◽

First Line Treatment

Download Full-text

56P Anti-PD1 antibody toripalimab, lenvatinib and gemox chemotherapy as first-line treatment of advanced and unresectable intrahepatic cholangiocarcinoma: A phase II clinical trial

Annals of Oncology ◽

10.1016/j.annonc.2020.08.034 ◽

2020 ◽

Vol 31 ◽

pp. S262-S263

Author(s):

J. Zhou ◽

J. Fan ◽

G. Shi ◽

X. Huang ◽

D. Wu ◽

...

Keyword(s):

Clinical Trial ◽

Phase Ii ◽

Intrahepatic Cholangiocarcinoma ◽

Phase Ii Clinical Trial ◽

Line Treatment ◽

First Line ◽

First Line Treatment

Download Full-text

Matuzumab plus epirubicin, cisplatin and capecitabine (ECX) compared with epirubicin, cisplatin and capecitabine alone as first-line treatment in patients with advanced oesophago-gastric cancer: a randomised, multicentre open-label phase II study

Annals of Oncology ◽

10.1093/annonc/mdq247 ◽

2010 ◽

Vol 21 (11) ◽

pp. 2213-2219 ◽

Cited By ~ 80

Author(s):

S. Rao ◽

N. Starling ◽

D. Cunningham ◽

K. Sumpter ◽

D. Gilligan ◽

...

Keyword(s):

Gastric Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Line Treatment ◽

First Line ◽

Open Label ◽

Open Label Phase ◽

First Line Treatment

Download Full-text

Bevacizumab versus placebo in combination with paclitaxel and carboplatin as first-line treatment for recurrent or metastatic nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase II trial

ESMO Open ◽

10.1016/j.esmoop.2021.100313 ◽

2021 ◽

Vol 6 (6) ◽

pp. 100313

Author(s):

T. Zhou ◽

Y. Yang ◽

S. Ma ◽

L. Lin ◽

T. Zhou ◽

...

Keyword(s):

Nasopharyngeal Carcinoma ◽

Phase Ii ◽

Phase Ii Trial ◽

Line Treatment ◽

First Line ◽

Open Label ◽

Metastatic Nasopharyngeal Carcinoma ◽

Open Label Phase ◽

First Line Treatment

Download Full-text

Phase II clinical trial using camrelizumab combined with apatinib and chemotherapy as the first‐line treatment of advanced esophageal squamous cell carcinoma

Cancer Communications ◽

10.1002/cac2.12119 ◽

2020 ◽

Vol 40 (12) ◽

pp. 711-720

Author(s):

Bo Zhang ◽

Ling Qi ◽

Xi Wang ◽

Jianping Xu ◽

Yun Liu ◽

...

Keyword(s):

Clinical Trial ◽

Squamous Cell Carcinoma ◽

Esophageal Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Phase Ii ◽

Squamous Cell ◽

Phase Ii Clinical Trial ◽

Line Treatment ◽

First Line ◽

First Line Treatment

Download Full-text

1131 POSTER Addition of CPG 7909 to taxane/platinum regimen for first-line treatment of unresectable NSCLC improves objective response in phase II clinical trial

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(05)81425-9 ◽

2005 ◽

Vol 3 (2) ◽

pp. 326-327 ◽

Cited By ~ 1

Keyword(s):

Clinical Trial ◽

Phase Ii ◽

Objective Response ◽

Phase Ii Clinical Trial ◽

Line Treatment ◽

First Line ◽

First Line Treatment

Download Full-text